evidence table
Probiotic Blood Pressure Meta-Analysis Evidence Table
Structured evidence table for Probiotic Blood Pressure Meta-Analysis, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Probiotic Blood Pressure Meta-Analysis | Background Metabolically dysfunction-associated steatotic liver disease (MASLD) is a growing public health challenge linked to obesity and metabolic dysregulation. | 1 | Jurek JM (2026) | Effects of Animal-Based Foods on Metabolic Outcomes in Adults with MASLD and Comorbidities: A Systematic Review of Randomized Controlled Trials (2020-2026). |
| Probiotic Blood Pressure Meta-Analysis | Objective This updated systematic review aims to evaluate evidence from randomized controlled trials (RCTs) regarding the effects of specific animal-based foods on metabolic, hepatic, and anthropometric outcomes in adults with MASLD. | 1 | Jurek JM (2026) | Effects of Animal-Based Foods on Metabolic Outcomes in Adults with MASLD and Comorbidities: A Systematic Review of Randomized Controlled Trials (2020-2026). |
| Probiotic Blood Pressure Meta-Analysis | The evidence is limited by small sample sizes in specific food categories and variability in dietary assessment methods. | 1 | Jurek JM (2026) | Effects of Animal-Based Foods on Metabolic Outcomes in Adults with MASLD and Comorbidities: A Systematic Review of Randomized Controlled Trials (2020-2026). |
| Probiotic Blood Pressure Meta-Analysis | Since pharmacological options are limited, Mediterranean (MED) and DASH patterns are recommended. | 1 | Jurek JM (2026) | Effects of Animal-Based Foods on Metabolic Outcomes in Adults with MASLD and Comorbidities: A Systematic Review of Randomized Controlled Trials (2020-2026). |
| Probiotic Blood Pressure Meta-Analysis | Trial sequential analysis confirmed that the evidence for LDL-C and insulin was sufficient to reach firm conclusions. | 1 | Zhong Y (2026) | Effects of probiotics on blood lipids, glucose and pressure in patients with coronary heart disease: a systematic review and meta-analysis. |
| Probiotic Blood Pressure Meta-Analysis | Conclusion Probiotics have been shown to significantly reduce LDL-C and insulin levels in patients with CHD without increasing the risk of adverse events. | 1 | Zhong Y (2026) | Effects of probiotics on blood lipids, glucose and pressure in patients with coronary heart disease: a systematic review and meta-analysis. |
| Probiotic Blood Pressure Meta-Analysis | Objective This study aims to investigate the effects of probiotic supplementation on blood glucose, lipids and pressure in patients with coronary heart disease (CHD) through systematic review and meta-analysis, combined with sequential trial analysis, and to assess its safety. | 1 | Zhong Y (2026) | Effects of probiotics on blood lipids, glucose and pressure in patients with coronary heart disease: a systematic review and meta-analysis. |
| Probiotic Blood Pressure Meta-Analysis | Methods A systematic search was conducted across five English-language databases: PubMed, Embase, Cochrane Library, Web of Science, and MEDLINE. | 1 | Zhong Y (2026) | Effects of probiotics on blood lipids, glucose and pressure in patients with coronary heart disease: a systematic review and meta-analysis. |
Source documents